Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
暂无分享,去创建一个
S. Parmar | M. Estecio | H. Kantarjian | G. Garcia-Manero | J. Cortes | C. Dinardo | S. Pierce | C. Bueso-Ramos | Z. Fang | Hui Yang | M. Nguyen | Yue Wei | Qi-rong Geng | M. Davanlou | C. Bueso‐Ramos | Zhihong Fang